MYRIAD GENETICS-GSK ALLIANCE ENHANCES HRD TESTING ACCESSIBILITY IN 9 COUNTRIES
KUALA LUMPUR, Myriad Genetics Inc announced a collaboration with GSK aimed at improving access to homologous recombination deficiency (HRD) diagnostic testing for high-grade serous ovarian cancer (HGSOC) patients.
A new sponsored testing programme l…